142 related articles for article (PubMed ID: 20079907)
1. Development and validation of new methods for the determination of melatonin and its oxidative metabolites by high performance liquid chromatography and capillary electrophoresis, using multivariate optimization.
Hevia D; Botas C; Sainz RM; Quiros I; Blanco D; Tan DX; Gomez-Cordoves C; Mayo JC
J Chromatogr A; 2010 Feb; 1217(8):1368-74. PubMed ID: 20079907
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes.
Silva SO; Rodrigues MR; Carvalho SR; Catalani LH; Campa A; Ximenes VF
J Pineal Res; 2004 Oct; 37(3):171-5. PubMed ID: 15357661
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
Mayo JC; Sainz RM; Tan DX; Hardeland R; Leon J; Rodriguez C; Reiter RJ
J Neuroimmunol; 2005 Aug; 165(1-2):139-49. PubMed ID: 15975667
[TBL] [Abstract][Full Text] [Related]
4. Optimized synthesis of the melatonin metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK).
Ximenes VF
J Pineal Res; 2008 Oct; 45(3):297-301. PubMed ID: 18373552
[TBL] [Abstract][Full Text] [Related]
5. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones.
Rosen J; Than NN; Koch D; Poeggeler B; Laatsch H; Hardeland R
J Pineal Res; 2006 Nov; 41(4):374-81. PubMed ID: 17014695
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction.
Ressmeyer AR; Mayo JC; Zelosko V; Sáinz RM; Tan DX; Poeggeler B; Antolín I; Zsizsik BK; Reiter RJ; Hardeland R
Redox Rep; 2003; 8(4):205-13. PubMed ID: 14599344
[TBL] [Abstract][Full Text] [Related]
7. Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the ABTS cation radical: identification of new oxidation products.
Than NN; Heer C; Laatsch H; Hardeland R
Redox Rep; 2006; 11(1):15-24. PubMed ID: 16571272
[TBL] [Abstract][Full Text] [Related]
8. High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism.
Silva SO; Ximenes VF; Livramento JA; Catalani LH; Campa A
J Pineal Res; 2005 Oct; 39(3):302-6. PubMed ID: 16150112
[TBL] [Abstract][Full Text] [Related]
9. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?
Tan DX; Manchester LC; Terron MP; Flores LJ; Reiter RJ
J Pineal Res; 2007 Jan; 42(1):28-42. PubMed ID: 17198536
[TBL] [Abstract][Full Text] [Related]
10. Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC.
Hevia D; Mayo JC; Quiros I; Gomez-Cordoves C; Sainz RM
Anal Bioanal Chem; 2010 Jun; 397(3):1235-44. PubMed ID: 20383699
[TBL] [Abstract][Full Text] [Related]
11. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice.
Manda K; Ueno M; Anzai K
J Pineal Res; 2007 Apr; 42(4):386-93. PubMed ID: 17439555
[TBL] [Abstract][Full Text] [Related]
12. Measurement of melatonin and its metabolites: importance for the evaluation of their biological roles.
Martinez GR; Almeida EA; Klitzke CF; Onuki J; Prado FM; Medeiros MH; Di Mascio P
Endocrine; 2005 Jul; 27(2):111-8. PubMed ID: 16217124
[TBL] [Abstract][Full Text] [Related]
13. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.
Galano A; Tan DX; Reiter RJ
J Pineal Res; 2013 Apr; 54(3):245-57. PubMed ID: 22998574
[TBL] [Abstract][Full Text] [Related]
14. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant.
Tan DX; Manchester LC; Burkhardt S; Sainz RM; Mayo JC; Kohen R; Shohami E; Huo YS; Hardeland R; Reiter RJ
FASEB J; 2001 Oct; 15(12):2294-6. PubMed ID: 11511530
[TBL] [Abstract][Full Text] [Related]
15. Melatonin: new places in therapy.
Maharaj DS; Glass BD; Daya S
Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
[TBL] [Abstract][Full Text] [Related]
16. Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine.
Seever K; Hardeland R
J Pineal Res; 2008 May; 44(4):450-5. PubMed ID: 18194200
[TBL] [Abstract][Full Text] [Related]
17. Analysis of organic components of smokeless gunpowders: high-performance liquid chromatogaphy vs. micellar electrokinetic capillary chromatography.
Cascio O; Trettene M; Bortolotti F; Milana G; Tagliaro F
Electrophoresis; 2004 Jun; 25(10-11):1543-7. PubMed ID: 15188239
[TBL] [Abstract][Full Text] [Related]
18. Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice.
Niu S; Li F; Tan DX; Zhang L; Idle JR; Gonzalez FJ; Ma X
J Pineal Res; 2010 Sep; 49(2):106-14. PubMed ID: 20545825
[TBL] [Abstract][Full Text] [Related]
19. On-line preconcentration techniques in determination of melatonin and its precursors/metabolites using micellar electrokinetic chromatography.
Musijowski J; Pobozy E; Trojanowicz M
J Chromatogr A; 2006 Feb; 1104(1-2):337-45. PubMed ID: 16343514
[TBL] [Abstract][Full Text] [Related]
20. Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro.
Bonnefont-Rousselot D; Collin F; Jore D; Gardès-Albert M
J Pineal Res; 2011 Apr; 50(3):328-35. PubMed ID: 21244479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
